Americas Renal Disease market

United states accounted for the largest market share in 2017 in the americas renal disease market, and is expected to reach usd 44690.64 million in 2023 from usd 30010.87 million in 2017.this market is projected to grow at a cagr of 7.05% during the forecast period from 2018 - 2023. dialysis segment accounted for the largest market share in 2017, this market is expected to reach usd 30238.79 million in 2023 from usd 20569.39 million in 2017. this market is projected to grow at a cagr of 6.81% during the forecast period from 2018 - 2023. however, medication segment is the fastest growing market, which is expected to grow at a cagr of 7.52% during the forecast period 2018 - 2023. chronic kidney disease segment accounted for the larger market share in 2017, this market is expected to reach usd 37760.75 million in 2023 from usd 25510.17 million in 2017. this market is projected to grow at a cagr of 6.94% during the forecast period from 2018 - 2023. however, chronic kidney disease segment is the fastest growing market, which is expected to grow at a cagr of 6.94% during the forecast period 2018 - 2023. dialysis centres segment accounted for the largest market share in 2017, this market is expected to reach usd 20137.71 million in 2023 from usd 13293.81 million in 2017. this market is projected to grow at a cagr of 7.35% during the forecast period from 2018 - 2023. however, dialysis centres segment is the fastest growing market, which is expected to grow at a cagr of 7.35% during the forecast period 2018 - 2023.